Cambridge Trust Co. Decreases Stock Holdings in Xylem Inc. (NYSE:XYL)

Cambridge Trust Co. trimmed its holdings in shares of Xylem Inc. (NYSE:XYL) by 7.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 145,457 shares of the industrial products company’s stock after selling 11,358 shares during the quarter. Cambridge Trust Co. owned 0.06% of Xylem worth $16,634,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. International Assets Investment Management LLC increased its position in shares of Xylem by 10,296.7% during the fourth quarter. International Assets Investment Management LLC now owns 63,004 shares of the industrial products company’s stock valued at $7,205,000 after acquiring an additional 62,398 shares during the last quarter. ING Groep NV purchased a new stake in Xylem in the third quarter worth $2,752,000. Meiji Yasuda Asset Management Co Ltd. increased its position in Xylem by 6.6% in the third quarter. Meiji Yasuda Asset Management Co Ltd. now owns 39,266 shares of the industrial products company’s stock worth $3,574,000 after buying an additional 2,438 shares during the last quarter. SG Americas Securities LLC increased its position in Xylem by 351.2% in the fourth quarter. SG Americas Securities LLC now owns 101,408 shares of the industrial products company’s stock worth $11,597,000 after buying an additional 78,934 shares during the last quarter. Finally, Mariner LLC increased its position in Xylem by 10.3% in the third quarter. Mariner LLC now owns 75,036 shares of the industrial products company’s stock worth $6,831,000 after buying an additional 7,006 shares during the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.

Xylem Trading Up 0.6 %

NYSE:XYL traded up $0.75 during mid-day trading on Thursday, reaching $126.97. 510,134 shares of the company’s stock traded hands, compared to its average volume of 1,138,997. Xylem Inc. has a 12-month low of $87.59 and a 12-month high of $130.86. The company has a 50 day moving average price of $126.85 and a 200-day moving average price of $112.01. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.76 and a quick ratio of 1.30. The firm has a market capitalization of $30.78 billion, a price-to-earnings ratio of 46.78, a PEG ratio of 2.55 and a beta of 1.10.

Xylem (NYSE:XYL) last posted its earnings results on Tuesday, February 6th. The industrial products company reported $0.99 earnings per share for the quarter, topping analysts’ consensus estimates of $0.96 by $0.03. Xylem had a return on equity of 9.65% and a net margin of 8.27%. The firm had revenue of $2.12 billion for the quarter, compared to the consensus estimate of $2.05 billion. During the same quarter in the prior year, the business earned $0.92 EPS. The business’s revenue for the quarter was up 40.6% on a year-over-year basis. On average, sell-side analysts predict that Xylem Inc. will post 4.13 earnings per share for the current year.

Xylem Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 20th. Investors of record on Wednesday, February 21st were given a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date of this dividend was Tuesday, February 20th. This is a positive change from Xylem’s previous quarterly dividend of $0.33. Xylem’s dividend payout ratio (DPR) is 52.94%.

Analyst Ratings Changes

A number of research firms have issued reports on XYL. Citigroup raised their target price on Xylem from $126.00 to $139.00 and gave the stock a “neutral” rating in a research report on Monday, April 8th. Stifel Nicolaus raised their target price on Xylem from $136.00 to $150.00 and gave the stock a “buy” rating in a research report on Wednesday, February 7th. BNP Paribas began coverage on Xylem in a research report on Tuesday, March 12th. They issued an “outperform” rating and a $150.00 target price for the company. Robert W. Baird lifted their price objective on Xylem from $141.00 to $148.00 and gave the company an “outperform” rating in a research note on Thursday, March 21st. Finally, Oppenheimer lifted their price objective on Xylem from $133.00 to $142.00 and gave the stock an “outperform” rating in a report on Thursday. Four analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $138.11.

Insider Buying and Selling at Xylem

In other Xylem news, SVP Franz Cerwinka sold 2,408 shares of the stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total transaction of $293,270.32. Following the sale, the senior vice president now directly owns 11,750 shares in the company, valued at approximately $1,431,032.50. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, SVP Franz Cerwinka sold 2,408 shares of Xylem stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $121.79, for a total transaction of $293,270.32. Following the transaction, the senior vice president now directly owns 11,750 shares in the company, valued at $1,431,032.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of Xylem stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total value of $122,890.00. Following the transaction, the chief accounting officer now owns 2,935 shares in the company, valued at $360,682.15. The disclosure for this sale can be found here. Company insiders own 0.27% of the company’s stock.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.